[Federal Register Volume 76, Number 64 (Monday, April 4, 2011)]
[Notices]
[Pages 18554-18555]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-7886]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-11-11DT]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-5960 or 
send comments to Daniel Holcomb, CDC Reports Clearance Officer, 1600 
Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to 
<a href="/cdn-cgi/l/email-protection#016e6c63416265622f666e77"><span class="__cf_email__" data-cfemail="aec1c3cceecdcacd80c9c1d8">[email protected]</span></a>.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    Monitoring Outcomes of the Enhanced Comprehensive HIV Prevention 
Planning (ECHPP) Project-New-National Center for HIV/AIDS, Viral 
Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The scope of the HIV epidemic in the United States is significant, 
particularly in large urban areas where HIV/AIDS cases are 
concentrated. In 2006, approximately 56,000 new HIV infections occurred 
in the U.S., demonstrating the need to expand targeted HIV prevention 
efforts. In 2010, twelve U.S. metropolitan statistical areas (MSAs) 
received funding, through their city and state health departments, to 
conduct the Enhanced Comprehensive HIV Prevention Planning (ECHPP) 
project. These twelve MSAs (Atlanta, GA; Baltimore, MD; Chicago, IL; 
Dallas, TX; District of Columbia; Houston, TX; Los Angeles, CA; Miami, 
FL; New York City, NY; Philadelphia, PA; San Francisco, CA; and San 
Juan, PR) had the highest AIDS prevalence rates in the U.S. at the end 
of 2007, representing 44% of all U.S. AIDS cases. The purpose of ECHPP 
is to enhance existing HIV prevention services in these high prevalence 
areas and provide an optimal mix of evidence-based behavioral, 
biomedical, and structural interventions to have maximum impact on the 
HIV/AIDS epidemic at the community level. ECHPP goals are consistent 
with CDC's Division of HIV/AIDS Prevention Strategic Plan for HIV 
Prevention and with the National HIV/AIDS Strategy: (1) Prevent new HIV 
infections, (2) increase linkage to, and impact of, prevention and care 
services for HIV-positive individuals, and (3) reduce HIV-related 
health disparities.
    To evaluate ECHPP, data will be collected through both existing CDC 
data sources and through new data collection activities. Existing CDC 
data sources will include HIV surveillance systems (e.g., National HIV 
Behavioral Surveillance System, Medical Monitoring Project) that 
routinely collect information about behavioral and clinical outcomes 
from at-risk target populations in the 12 MSAs. A new data collection 
activity is proposed through this project to collect information about 
behavioral and clinical outcomes from injection drug users, high-risk 
heterosexuals, and HIV-positive individuals who access medical care in 
six of the 12 ECHPP-funded MSAs. These MSAs are: District of Columbia; 
Houston, TX; Los Angeles, CA; Miami, FL; New York City, NY; and San 
Francisco, CA. The purpose of this new data collection activity is to 
monitor community-level outcomes of ECHPP and supplement HIV 
surveillance data routinely collected in these areas. Outcome data will 
be collected in these MSAs at two time points from 2011 to 2014.
    Two surveys will be used in this project: (1) A community-based 
survey to be administered to injection drug users and high-risk 
heterosexuals, and (2) a clinic-based survey to be administered to HIV-
positive individuals seeking care at clinics that provide HIV-related 
services. Both surveys will collect data on demographics, sexual 
behavior, alcohol and drug use history, HIV testing experiences, 
exposure to HIV prevention messages, and participation in HIV 
prevention activities. The clinic survey will also include questions 
about HIV treatment, treatment adherence, sources of care, and medical 
outcomes. For the community survey, we intend to recruit and screen 
1500 injection drug users and 1500 high-risk heterosexuals using venue-
based, convenience sampling methods. For the clinic survey, we intend 
to recruit and screen 2400 HIV-positive individuals seeking HIV care at 
medical clinics. A total of 1200 eligible injection drug users (age >= 
18 yrs), 1200 eligible high-risk heterosexuals (age 18 to 60 yrs), and 
2400 eligible HIV-positive individuals (age >= 18 yrs) will be 
surveyed. CDC will collaborate with local health department staff and 
outreach workers in each MSA to identify venues and clinics appropriate 
for data collection. Surveys will be administered by trained, local 
interviewers. There is no cost to respondents other than their time.

                                       Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                 Data collection     Number of       Number of      burden per     Total burden
       Target population              form          respondents    responses per   response  (in    (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Injection drug users..........  Community                    500               1            5/60              42
                                 Screener.
Eligible injection drug users.  Community Survey             400               1           25/60             167
High-risk heterosexual          Community                    500               1            5/60              42
 individuals.                    Screener.
Eligible high-risk              Community Survey             400               1           25/60             167
 heterosexual individuals.
HIV-positive individuals......  Clinic Screener.             933               1            5/60              78

[[Page 18555]]

 
Eligible HIV-positive           Clinic Survey...             800               1           25/60             333
 individuals.
                               ---------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............             829
----------------------------------------------------------------------------------------------------------------


Daniel Holcomb,
Reports Clearance Officer, Centers for Disease Control and Prevention.
[FR Doc. 2011-7886 Filed 4-1-11; 8:45 am]
BILLING CODE 4163-18-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>